Clinical Trial Update: Safety and Efficacy of Once-daily Oral Administrations of TZP-102 for Gastroparesis in Patients With Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of once-daily oral TZP-102 for gastroparesis in patients with diabetes mellitus; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Gastroparesis

Drugs mentioned

• TZP-102

Snippet

Sponsor: Tranzyme, Inc. | Conditions: Gastroparesis, Diabetes Mellitus | Phase 2 | Status: COMPLETED